Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Budigalimab
Trade Name
Synonyms ABBV181|ABBV 181|ABBV-181
Drug Descriptions

Budigalimab is a monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (PMID: 32770720).

DrugClasses Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121
CAS Registry Number 2098225-93-3
NCIT ID C137682

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ABBV-011 + Budigalimab ABBV-011 Budigalimab 0 1
ABBV-151 + Budigalimab ABBV-151 Budigalimab 0 3
ABBV-151 + Budigalimab + Carboplatin + Pemetrexed Disodium ABBV-151 Budigalimab Carboplatin Pemetrexed Disodium 0 1
ABBV-151 + Budigalimab + Cisplatin + Pemetrexed Disodium ABBV-151 Budigalimab Cisplatin Pemetrexed Disodium 0 1
ABBV-151 + Budigalimab + Pemetrexed Disodium ABBV-151 Budigalimab Pemetrexed Disodium 0 1
ABBV-303 + Budigalimab ABBV-303 Budigalimab 0 1
ABBV-368 + ABBV-927 + Budigalimab ABBV-368 ABBV-927 Budigalimab 0 1
ABBV-368 + Budigalimab + IMO-2125 + Nab-paclitaxel ABBV-368 Budigalimab IMO-2125 Nab-paclitaxel 0 1
ABBV-514 + Budigalimab ABBV-514 Budigalimab 0 1
ABBV-706 + Budigalimab ABBV-706 Budigalimab 0 1
ABBV-927 + Budigalimab + Carboplatin ABBV-927 Budigalimab Carboplatin 0 1
ABBV-927 + Budigalimab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin ABBV-927 Budigalimab Fluorouracil Irinotecan Leucovorin Oxaliplatin 0 1
ABT-165 + Budigalimab ABT-165 Budigalimab 0 1
ABT-165 + Budigalimab + Paclitaxel ABT-165 Budigalimab Paclitaxel 0 1
Budigalimab Budigalimab 0 2
Budigalimab + Carboplatin + Pemetrexed Disodium Budigalimab Carboplatin Pemetrexed Disodium 0 1
Budigalimab + Cisplatin + Pemetrexed Disodium Budigalimab Cisplatin Pemetrexed Disodium 0 1
Budigalimab + Fluorouracil + Leucovorin + Oxaliplatin + TTX-030 Budigalimab Fluorouracil Leucovorin Oxaliplatin TTX-030 0 0
Budigalimab + Gemcitabine + Nab-paclitaxel + TTX-030 Budigalimab Gemcitabine Nab-paclitaxel TTX-030 0 1
Budigalimab + Rovalpituzumab Tesirine Budigalimab Rovalpituzumab Tesirine 0 0
Budigalimab + SC-003 Budigalimab SC-003 0 1
Budigalimab + SC-004 Budigalimab SC-004 0 1
Budigalimab + SC-006 Budigalimab SC-006 0 0
Budigalimab + TTX-030 Budigalimab TTX-030 0 0


Additional content available in CKB BOOST